These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 27670087)
1. Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes. Li CW; Osman R; Menconi F; Concepcion ES; Tomer Y J Autoimmun; 2017 Jan; 76():1-9. PubMed ID: 27670087 [TBL] [Abstract][Full Text] [Related]
2. Cepharanthine Blocks Presentation of Thyroid and Islet Peptides in a Novel Humanized Autoimmune Diabetes and Thyroiditis Mouse Model. Li CW; Osman R; Menconi F; Faustino LC; Kim K; Clarke OB; Hou H; Tomer Y Front Immunol; 2021; 12():796552. PubMed ID: 34987519 [TBL] [Abstract][Full Text] [Related]
3. Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis. Menconi F; Osman R; Monti MC; Greenberg DA; Concepcion ES; Tomer Y Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16899-903. PubMed ID: 20837527 [TBL] [Abstract][Full Text] [Related]
4. Tg.2098 is a major human thyroglobulin T-cell epitope. Menconi F; Huber A; Osman R; Concepcion E; Jacobson EM; Stefan M; David CS; Tomer Y J Autoimmun; 2010 Aug; 35(1):45-51. PubMed ID: 20303712 [TBL] [Abstract][Full Text] [Related]
5. Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease. Li CW; Osman R; Menconi F; Concepcion E; Tomer Y J Autoimmun; 2020 Mar; 108():102402. PubMed ID: 31980336 [TBL] [Abstract][Full Text] [Related]
6. Effective Inhibition of Thyroid Antigen Presentation Using Retro-Inverso Peptides in Experimental Autoimmune Thyroiditis: A Pathway Toward Immune Therapies of Thyroid Autoimmunity. Li CW; Osman R; Menconi F; Hou H; Schechter C; Kozhakhmetova A; Tomer Y Thyroid; 2023 Apr; 33(4):492-500. PubMed ID: 36762945 [No Abstract] [Full Text] [Related]
7. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis. Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030 [TBL] [Abstract][Full Text] [Related]
8. Genome wide identification of new genes and pathways in patients with both autoimmune thyroiditis and type 1 diabetes. Tomer Y; Dolan LM; Kahaly G; Divers J; D'Agostino RB; Imperatore G; Dabelea D; Marcovina S; Black MH; Pihoker C; Hasham A; Hammerstad SS; Greenberg DA; Lotay V; Zhang W; Monti MC; Matheis N; J Autoimmun; 2015 Jun; 60():32-9. PubMed ID: 25936594 [TBL] [Abstract][Full Text] [Related]
9. Superiority of thyroid peroxidase DNA over protein immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301 (DR3) transgenic mice. Flynn JC; Gardas A; Wan Q; Gora M; Alsharabi G; Wei WZ; Giraldo AA; David CS; Kong YM; Banga JP Clin Exp Immunol; 2004 Sep; 137(3):503-12. PubMed ID: 15320899 [TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic characteristics of autoimmune polyglandular syndrome type 3 variant in the Japanese population. Horie I; Kawasaki E; Ando T; Kuwahara H; Abiru N; Usa T; Yamasaki H; Ejima E; Kawakami A J Clin Endocrinol Metab; 2012 Jun; 97(6):E1043-50. PubMed ID: 22466347 [TBL] [Abstract][Full Text] [Related]
11. Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice. Menconi F; Monti MC; Greenberg DA; Oashi T; Osman R; Davies TF; Ban Y; Jacobson EM; Concepcion ES; Li CW; Tomer Y Proc Natl Acad Sci U S A; 2008 Sep; 105(37):14034-9. PubMed ID: 18779568 [TBL] [Abstract][Full Text] [Related]
12. HLA-DR binding analysis of peptides from islet antigens in IDDM. Geluk A; van Meijgaarden KE; Schloot NC; Drijfhout JW; Ottenhoff TH; Roep BO Diabetes; 1998 Oct; 47(10):1594-601. PubMed ID: 9753297 [TBL] [Abstract][Full Text] [Related]
13. Clinical and genetic characteristics of patients with autoimmune thyroid disease with anti-islet autoimmunity. Moriguchi M; Noso S; Kawabata Y; Yamauchi T; Harada T; Komaki K; Babaya N; Hiromine Y; Ito H; Yamagata S; Murata K; Higashimoto T; Park C; Yamamoto A; Ohno Y; Ikegami H Metabolism; 2011 Jun; 60(6):761-6. PubMed ID: 20825955 [TBL] [Abstract][Full Text] [Related]
14. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR. van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of HLA-DRB1∗03:01 and H2E transgenic mouse strains to correlate pathogenic thyroglobulin epitopes for autoimmune thyroiditis. Kong YC; Brown NK; Flynn JC; McCormick DJ; Brusic V; Morris GP; David CS J Autoimmun; 2011 Sep; 37(2):63-70. PubMed ID: 21683551 [TBL] [Abstract][Full Text] [Related]
16. Thyroglobulin peptides associate in vivo to HLA-DR in autoimmune thyroid glands. Muixí L; Carrascal M; Alvarez I; Daura X; Martí M; Armengol MP; Pinilla C; Abian J; Pujol-Borrell R; Jaraquemada D J Immunol; 2008 Jul; 181(1):795-807. PubMed ID: 18566446 [TBL] [Abstract][Full Text] [Related]
17. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens. Honeyman MC; Stone NL; Falk BA; Nepom G; Harrison LC J Immunol; 2010 Feb; 184(4):2204-10. PubMed ID: 20083660 [TBL] [Abstract][Full Text] [Related]
18. Human thyroglobulin peptide p2340 induces autoimmune thyroiditis in HLA-DR3 transgenic mice. Karras E; Yang H; Lymberi P; Christadoss P J Autoimmun; 2005 Jun; 24(4):291-6. PubMed ID: 15927791 [TBL] [Abstract][Full Text] [Related]
19. Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis. Flynn JC; McCormick DJ; Brusic V; Wan Q; Panos JC; Giraldo AA; David CS; Kong YC Cell Immunol; 2004 Jun; 229(2):79-85. PubMed ID: 15474522 [TBL] [Abstract][Full Text] [Related]
20. Employing a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective. Jacobson EM; Yang H; Menconi F; Wang R; Osman R; Skrabanek L; Li CW; Fadlalla M; Gandhi A; Chaturvedi V; Smith EP; Schwemberger S; Osterburg A; Babcock GF; Tomer Y J Biol Chem; 2009 Dec; 284(49):34231-43. PubMed ID: 19776016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]